1.
Davidoff AJ, Smith SW, Baer MR, Ke X, Bierenbaum JM, Hendrick F, McNally DL, Gore SD. Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes. Haematologica [Internet]. 2011Dec.30 [cited 2026Nov.16];97(1):128-32. Available from: https://haematologica.org/article/view/6175